ALC Stock Overview
Engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom.
Snowflake Score | |
---|---|
Valuation | 5/6 |
Future Growth | 4/6 |
Past Performance | 0/6 |
Financial Health | 5/6 |
Dividends | 0/6 |
Alcidion Group Limited Competitors
Price History & Performance
Historical stock prices | |
---|---|
Current Share Price | AU$0.079 |
52 Week High | AU$0.13 |
52 Week Low | AU$0.04 |
Beta | 1.55 |
11 Month Change | 41.07% |
3 Month Change | 33.90% |
1 Year Change | -28.18% |
33 Year Change | -78.06% |
5 Year Change | -56.11% |
Change since IPO | 21.54% |
Recent News & Updates
Alcidion Group Limited (ASX:ALC) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 16Here's Why We're Not Too Worried About Alcidion Group's (ASX:ALC) Cash Burn Situation
Jul 24Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet
Jun 14Recent updates
Alcidion Group Limited (ASX:ALC) Held Back By Insufficient Growth Even After Shares Climb 41%
Aug 16Here's Why We're Not Too Worried About Alcidion Group's (ASX:ALC) Cash Burn Situation
Jul 24Benign Growth For Alcidion Group Limited (ASX:ALC) Underpins Stock's 28% Plummet
Jun 14We're Hopeful That Alcidion Group (ASX:ALC) Will Use Its Cash Wisely
Apr 24Little Excitement Around Alcidion Group Limited's (ASX:ALC) Revenues As Shares Take 29% Pounding
Jan 30Shareholders Will Probably Hold Off On Increasing Alcidion Group Limited's (ASX:ALC) CEO Compensation For The Time Being
Nov 13Companies Like Alcidion Group (ASX:ALC) Can Afford To Invest In Growth
Oct 19We're Interested To See How Alcidion Group (ASX:ALC) Uses Its Cash Hoard To Grow
Jul 17Is There An Opportunity With Alcidion Group Limited's (ASX:ALC) 45% Undervaluation?
Jun 02Alcidion Group Limited (ASX:ALC) Just Reported And Analysts Have Been Cutting Their Estimates
Feb 25When Should You Buy Alcidion Group Limited (ASX:ALC)?
Nov 02When Will Alcidion Group Limited (ASX:ALC) Breakeven?
Apr 15Calculating The Fair Value Of Alcidion Group Limited (ASX:ALC)
Mar 28Shareholder Returns
ALC | AU Healthcare Services | AU Market | |
---|---|---|---|
7D | 6.8% | 16.2% | 2.6% |
1Y | -28.2% | 95.4% | 10.6% |
Return vs Industry: ALC underperformed the Australian Healthcare Services industry which returned 91.4% over the past year.
Return vs Market: ALC underperformed the Australian Market which returned 9.2% over the past year.
Price Volatility
ALC volatility | |
---|---|
ALC Average Weekly Movement | 11.4% |
Healthcare Services Industry Average Movement | 8.3% |
Market Average Movement | 8.1% |
10% most volatile stocks in AU Market | 16.8% |
10% least volatile stocks in AU Market | 3.4% |
Stable Share Price: ALC's share price has been volatile over the past 3 months.
Volatility Over Time: ALC's weekly volatility (11%) has been stable over the past year.
About the Company
Founded | Employees | CEO | Website |
---|---|---|---|
2000 | 191 | Kate Quirke | www.alcidion.com |
Alcidion Group Limited, together with its subsidiaries, engages in the development and licensing of healthcare software products in Australia, New Zealand, and the United Kingdom. The company offers Miya Precision, a consolidated fast healthcare interoperability resource (FHIR) based platform to deliver smart healthcare; Smartpage, a smartphone and web-based system for hospital communication and task management to address the requirements of clinical and non-clinical users; Patientrack, a real-time patient monitoring and risk screening solution; Silverlink, a patient administration system; and ExtraMed, a clinical and patient flow management software. It also provides product implementation, product support and maintenance, systems integration, and data analysis services.
Alcidion Group Limited Fundamentals Summary
ALC fundamental statistics | |
---|---|
Market cap | AU$106.06m |
Earnings (TTM) | -AU$5.11m |
Revenue (TTM) | AU$40.48m |
2.6x
P/S Ratio-20.8x
P/E RatioIs ALC overvalued?
See Fair Value and valuation analysisEarnings & Revenue
ALC income statement (TTM) | |
---|---|
Revenue | AU$40.48m |
Cost of Revenue | AU$5.30m |
Gross Profit | AU$35.17m |
Other Expenses | AU$40.28m |
Earnings | -AU$5.11m |
Last Reported Earnings
Dec 31, 2023
Next Earnings Date
n/a
Earnings per share (EPS) | -0.0038 |
Gross Margin | 86.90% |
Net Profit Margin | -12.63% |
Debt/Equity Ratio | 0% |
How did ALC perform over the long term?
See historical performance and comparison